• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于生存的生物信息学方法筛选肝细胞癌中作为预后生物标志物的miRNA及其相关枢纽靶点。

Screening of miRNAs as prognostic biomarkers and their associated hub targets across Hepatocellular carcinoma using survival-based bioinformatics approach.

作者信息

Singh Prithvi, Solanki Rubi, Tasneem Alvea, Suri Simran, Kaur Harleen, Shah Sapna Ratan, Dohare Ravins

机构信息

Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi 110025, India.

School of Interdisciplinary Sciences and Technology, Jamia Hamdard, New Delhi 110062, India.

出版信息

J Genet Eng Biotechnol. 2024 Mar;22(1):100337. doi: 10.1016/j.jgeb.2023.100337. Epub 2024 Jan 24.

DOI:10.1016/j.jgeb.2023.100337
PMID:38494261
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11630632/
Abstract

BACKGROUND

The hepatocellular carcinoma (HCC) incident rate is gradually increasing yearly despite all the research and efforts taken by scientific communities and governing bodies. Approximately 90% of all liver cancer cases belong to HCC. Usually, HCC patients approach the treatment in the late stages of this malignancy which becomes the primary cause of high mortality rate. The knowledge about molecular pathogenesis of HCC is limited and needs more attention from researchers to identify the driver genes and miRNAs, which causes to translate this information into clinical practice. Therefore, the key regulators identification of miRNA-mRNA regulatory network is essential to identify HCC-associated genes.

METHODOLOGY

We extracted microRNA (miRNA) and messenger RNA (mRNA) expression datasets of normal and tumor HCC patient samples from UCSC Xena followed by identifying differentially expressed genes (DEGs) and differentially expressed miRNAs (DEMs). Univariate and multivariate cox-proportional hazard models were utilized to identify DEMs having significant association with overall survival (OS). Kaplan-Meier (KM) plotter was used to validate the presence of prognostic DEMs. A risk-score model was used to evaluate the effectiveness of KM-plotter validated DEMs combination on risk of samples. Target DEGs of prognostic miRNAs were identified via sources such as miRTargetLink and miRWalk followed by their validation in an external microarray cohort and enrichment analysis.

RESULTS

562 DEGs and 388 DEMs were identified followed by seven prognostic miRNAs (i.e., miR-19a, miR-19b, miR-30d-5p, miR-424-5p, miR-3677-5p, miR-3913-5p, miR-7705) post univariate, multivariate, risk-score model evaluation and KM-plotter analyses. ANLN, MRO, CPEB3 were their targets and were also validated in GSE84005 dataset.

CONCLUSIONS

The findings of this study decipher that most significant miRNAs and their identified target genes have association with apoptosis, inflammation, cell cycle regulation and cancer-related pathways, which appear to contribute to HCC pathogenesis and therefore, the discovery of new targets.

摘要

背景

尽管科学界和管理机构进行了所有研究并付出了努力,但肝细胞癌(HCC)的发病率仍逐年逐渐上升。所有肝癌病例中约90%属于HCC。通常,HCC患者在这种恶性肿瘤的晚期才接受治疗,这成为高死亡率的主要原因。关于HCC分子发病机制的知识有限,需要研究人员更多关注以识别驱动基因和miRNA,从而将这些信息转化为临床实践。因此,识别miRNA-mRNA调控网络的关键调节因子对于识别HCC相关基因至关重要。

方法

我们从UCSC Xena中提取了正常和肿瘤HCC患者样本的微小RNA(miRNA)和信使核糖核酸(mRNA)表达数据集,随后识别差异表达基因(DEG)和差异表达miRNA(DEM)。使用单变量和多变量cox比例风险模型来识别与总生存期(OS)有显著关联的DEM。使用Kaplan-Meier(KM)绘图仪验证预后DEM的存在。使用风险评分模型评估经KM绘图仪验证的DEM组合对样本风险的有效性。通过miRTargetLink和miRWalk等来源识别预后miRNA的靶标DEG,随后在外部微阵列队列中对其进行验证并进行富集分析。

结果

在单变量、多变量、风险评分模型评估和KM绘图仪分析后,识别出562个DEG和388个DEM,以及7个预后miRNA(即miR-19a、miR-19b、miR-30d-5p、miR-424-5p、miR-3677-5p、miR-3913-5p、miR-7705)。ANLN、MRO、CPEB3是它们的靶标,并且也在GSE84005数据集中得到验证。

结论

本研究结果表明,最显著的miRNA及其识别出的靶标基因与细胞凋亡、炎症、细胞周期调控和癌症相关途径有关,这似乎有助于HCC发病机制,因此有助于发现新的靶标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd0d/11630632/d65834bfef79/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd0d/11630632/91771c8f2c8e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd0d/11630632/39096def6440/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd0d/11630632/6611cdd17081/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd0d/11630632/ab0d8d0a0498/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd0d/11630632/e6d3bdd2e578/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd0d/11630632/ef61f198fbed/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd0d/11630632/d65834bfef79/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd0d/11630632/91771c8f2c8e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd0d/11630632/39096def6440/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd0d/11630632/6611cdd17081/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd0d/11630632/ab0d8d0a0498/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd0d/11630632/e6d3bdd2e578/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd0d/11630632/ef61f198fbed/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd0d/11630632/d65834bfef79/gr7.jpg

相似文献

1
Screening of miRNAs as prognostic biomarkers and their associated hub targets across Hepatocellular carcinoma using survival-based bioinformatics approach.基于生存的生物信息学方法筛选肝细胞癌中作为预后生物标志物的miRNA及其相关枢纽靶点。
J Genet Eng Biotechnol. 2024 Mar;22(1):100337. doi: 10.1016/j.jgeb.2023.100337. Epub 2024 Jan 24.
2
Identification of lncRNA/circRNA-miRNA-mRNA ceRNA Network as Biomarkers for Hepatocellular Carcinoma.鉴定lncRNA/circRNA-miRNA-mRNA ceRNA网络作为肝细胞癌的生物标志物
Front Genet. 2022 Mar 21;13:838869. doi: 10.3389/fgene.2022.838869. eCollection 2022.
3
Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma.构建并验证三 miRNA 标志物作为肝癌患者的预后生物标志物。
Int J Med Sci. 2021 Jan 1;18(4):984-999. doi: 10.7150/ijms.49126. eCollection 2021.
4
Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.鉴定参与 HBV 相关 HCC 发病机制的潜在 miRNA-mRNA 调控网络。
J Transl Med. 2019 Jan 3;17(1):7. doi: 10.1186/s12967-018-1761-7.
5
Identification of potentially functional circular RNAs hsa_circ_0070934 and hsa_circ_0004315 as prognostic factors of hepatocellular carcinoma by integrated bioinformatics analysis.通过综合生物信息学分析鉴定出潜在功能的环状 RNA hsa_circ_0070934 和 hsa_circ_0004315 作为肝细胞癌的预后因素。
Sci Rep. 2022 Mar 23;12(1):4933. doi: 10.1038/s41598-022-08867-w.
6
Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer.利用生物信息学分析非小细胞肺癌患者血浆中潜在的 miRNA-mRNA 调控网络。
BMC Cancer. 2022 Mar 21;22(1):299. doi: 10.1186/s12885-022-09281-1.
7
Integrated analysis of lncRNA-associated ceRNA network reveals potential biomarkers for the prognosis of hepatitis B virus-related hepatocellular carcinoma.lncRNA相关ceRNA网络的综合分析揭示了乙型肝炎病毒相关肝细胞癌预后的潜在生物标志物。
Cancer Manag Res. 2019 Jan 17;11:877-897. doi: 10.2147/CMAR.S186561. eCollection 2019.
8
Bioinformatics Analyses of Potential miRNA-mRNA Regulatory Axis in HBV-related Hepatocellular Carcinoma.基于生物信息学分析乙型肝炎病毒相关性肝细胞癌中潜在的 miRNA-mRNA 调控轴。
Int J Med Sci. 2021 Jan 1;18(2):335-346. doi: 10.7150/ijms.50126. eCollection 2021.
9
Bioinformatics Analysis Identifies the Estrogen Receptor 1 (ESR1) Gene and hsa-miR-26a-5p as Potential Prognostic Biomarkers in Patients with Intrahepatic Cholangiocarcinoma.生物信息学分析鉴定出雌激素受体 1 (ESR1) 基因和 hsa-miR-26a-5p 是肝内胆管癌患者的潜在预后生物标志物。
Med Sci Monit. 2020 May 21;26:e921815. doi: 10.12659/MSM.921815.
10
Bioinformatics Analysis of Choriocarcinoma-Related MicroRNA-Transcription Factor-Target Gene Regulatory Networks and Validation of Key miRNAs.绒毛膜癌相关微小RNA-转录因子-靶基因调控网络的生物信息学分析及关键微小RNA的验证
Onco Targets Ther. 2021 Jun 29;14:3903-3919. doi: 10.2147/OTT.S311291. eCollection 2021.

引用本文的文献

1
Exploring miRNA profile associated with cisplatin resistance in ovarian cancer cells.探索与卵巢癌细胞顺铂耐药相关的微小RNA谱。
Biochem Biophys Rep. 2024 Dec 26;41:101906. doi: 10.1016/j.bbrep.2024.101906. eCollection 2025 Mar.
2
Investigating the role of prognostic mitophagy-related genes in non-small cell cancer pathogenesis via multiomics and network-based approach.通过多组学和基于网络的方法研究预后性线粒体自噬相关基因在非小细胞癌发病机制中的作用。
3 Biotech. 2024 Nov;14(11):273. doi: 10.1007/s13205-024-04127-y. Epub 2024 Oct 21.
3
Identification of a prognostic gene signature in patients with cisplatin resistant squamous cell lung cancer.

本文引用的文献

1
Breast Cancer Prognostic Hub Genes Identified by Integrated Transcriptomic and Weighted Network Analysis: A Road Toward Personalized Medicine.基于转录组学整合和加权网络分析鉴定的乳腺癌预后枢纽基因:迈向个体化医学之路。
OMICS. 2023 May;27(5):227-236. doi: 10.1089/omi.2023.0033. Epub 2023 May 8.
2
Integrative Multiomics and Regulatory Network Analyses Uncovers the Role of OAS3, TRAFD1, miR-222-3p, and miR-125b-5p in Hepatitis E Virus Infection.整合多组学和调控网络分析揭示 OAS3、TRAFD1、miR-222-3p 和 miR-125b-5p 在戊型肝炎病毒感染中的作用。
Genes (Basel). 2022 Dec 23;14(1):42. doi: 10.3390/genes14010042.
3
Unravelling hub genes as potential therapeutic targets in lung cancer using integrated transcriptomic meta-analysis and in silico approach.
顺铂耐药性肺鳞状细胞癌患者预后基因特征的鉴定
J Thorac Dis. 2024 Jul 30;16(7):4567-4583. doi: 10.21037/jtd-24-827. Epub 2024 Jul 26.
利用综合转录组元分析和计算机模拟方法揭示肺癌中作为潜在治疗靶点的枢纽基因。
J Biomol Struct Dyn. 2023 Oct-Nov;41(18):9089-9102. doi: 10.1080/07391102.2022.2140200. Epub 2022 Nov 1.
4
MicroRNA as a Potential Therapeutic Molecule in Cancer.微小 RNA 作为癌症治疗的潜在分子
Cells. 2022 Mar 16;11(6):1008. doi: 10.3390/cells11061008.
5
Potential plasma biomarkers: miRNA-29c, miRNA-21, and miRNA-155 in clinical progression of Hepatocellular Carcinoma patients.潜在的血浆生物标志物:miRNA-29c、miRNA-21 和 miRNA-155 在肝癌患者的临床进展中的作用。
PLoS One. 2022 Feb 14;17(2):e0263298. doi: 10.1371/journal.pone.0263298. eCollection 2022.
6
A Novel Risk-Score Model With Eight MiRNA Signatures for Overall Survival of Patients With Lung Adenocarcinoma.一种具有八个微小RNA特征的新型风险评分模型用于肺腺癌患者的总生存期评估
Front Genet. 2021 Nov 12;12:741112. doi: 10.3389/fgene.2021.741112. eCollection 2021.
7
Risk Factors and Prevention of Viral Hepatitis-Related Hepatocellular Carcinoma.病毒性肝炎相关肝细胞癌的危险因素与预防
Front Oncol. 2021 Sep 9;11:686962. doi: 10.3389/fonc.2021.686962. eCollection 2021.
8
Elevated exosome-derived miRNAs predict osimertinib resistance in non-small cell lung cancer.外泌体来源的miRNA水平升高预示非小细胞肺癌对奥希替尼耐药。
Cancer Cell Int. 2021 Aug 14;21(1):428. doi: 10.1186/s12935-021-02075-8.
9
Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation.专为医学研究量身定制的基于网络的生存分析工具(KMplot):开发与应用
J Med Internet Res. 2021 Jul 26;23(7):e27633. doi: 10.2196/27633.
10
Establishment of a prognostic-related microRNAs risk model for glioma by bioinformatics analysis.通过生物信息学分析建立胶质瘤预后相关的微小RNA风险模型。
Ann Transl Med. 2021 Jun;9(12):1022. doi: 10.21037/atm-21-2402.